City
Epaper

Plan to increase Sputnik V vaccine production up to 850 million doses per year in India: Russian envoy

By ANI | Updated: May 1, 2021 17:35 IST

Expressing his happiness at the delivery of the first batch of Sputnik V vaccine to India, Russian envoy Nikolay Kudashev on Saturday said that the local production is about to start soon and is planned to be gradually increased up to 850 million doses per year.

Open in App

Expressing his happiness at the delivery of the first batch of Sputnik V vaccine to India, Russian envoy Nikolay Kudashev on Saturday said that the local production is about to start soon and is planned to be gradually increased up to 850 million doses per year.

Earlier today, a flight carrying the first lot of Russian vaccines landed in Hyderabad, Telangana.

"Happy to share that the first batch of the Sputnik V vaccine was delivered in Hyderabad today! As Russia and India continue dedicated joint efforts to combat the #COVID19, this move is especially important to support the Indian Government's endeavours to mitigate the deadly second wave and save lives," said Ambassador Kudashev

The Russian envoy also said that the efficacy of the Sputnik V in among the highest in the world, and this vaccine will also be effective against new strains of COVID-19,

"Its local production is about to start soon and is planned to be gradually increased up to 850 million doses per year. Look forward to further expand our bilateral and multilateral cooperation with India to stop the pandemic," he added.

Last month, the Drug Controller General (DCGI) had issued permission for Dr Reddy's Laboratories to import the Russian vaccine to India for emergency use.

The rollout of the Russian vaccine is expected to augment India's third phase of the vaccination drive which commenced today amid a record rise in COVID-19 cases.

India for the first time has reported more than 4 lakh new COVID-19 cases in the last 24 hours. A total of 4,01,993 fresh COVID-19 cases were recorded in the last 24 hours taking the cumulative count of the cases to 1,91,64,969, the Union Health Ministry reported on Saturday.

Sputnik V is the third vaccine India has given the go-ahead to after 'Covishield', developed by Oxford University and AstraZeneca and 'Covaxin', the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.

Diplomatic sources had toldthat India will get a substantive number of vaccines in the first tranche and the supply will continue in instalments. India is expecting 5 million vials of Sputnik vaccines by the next month.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: indiaHyderabadUnion Health MinistryOxford UniversityNagarNikolay kudashevHyderIndiUk-indiaRepublic of india
Open in App

Related Stories

NationalDonald Trump Imposes Additional 25% Tariff on India, Total Tariff Now 50%

TechnologyWill the Government Have to Offer More Incentives on EVs? NITI Aayog Raises Concerns Over Slow Sales Growth

OpinionsWhy is Trump So Upset with India?

MumbaiUniversity of Bristol Chooses Mumbai for Its First Overseas Campus, Set to Open in September 2026

NationalRaksha Bandhan 2025: Now You Can Send a Rakhi to Your Brother in India Post's Waterproof Envelope — Here's How to Track Your Parcel

International Realted Stories

InternationalMan charged with murder of Indian student Harsimrat Randhawa in Canada, arrested

InternationalIsraeli PM Netanyahu meets Indian envoy, vows to deepen strategic ties

InternationalSouth Korea: Unification Church leader's aide appears for questioning over ex-first lady allegations

InternationalTrump's tariffs risk carefully-built US-India partnership, US Senator says

InternationalDiplomatic efforts initiated for search of 17 Nepali nationals missing in Uttarakhand floods: Nepal PM Oli